Vectors that repress heterologous promoter activity
US6730511B1 · kind B1 · utility
1Cited by
0References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1997 |
| Grant date | May 4, 2004 |
| Priority date | — |
| Expiry date | Sep 8, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/13043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention refers to a novel recombinant vectors useful for gene therapy of viral infections and of diseases associated with B and T cells. The present invention relates, furthermore, to novel usages of the two products of the open reading frame of mouse mammary tumour virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.